Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Repeated scanning ultrasound in the absence of a therapeutic agent removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results support previous studies showing improved behaviour in AD mouse models associated with enhanced microglial amyloid plaque phagocytosis in response to scanning ultrasound69, and treatment with IL-33 that signals exclusively via MyD8870.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [69]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“An entire series of sections was processed for Campbell-Switzer silver staining (36) using a protocol available online at http://neuroscienceassociates.”
MethodScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Ab is elevated in the AD brain because of the increased production of this peptide and its impaired removal (4, 5).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“At the age of 12 to 13 months, APP23 mice have a substantial plaque burden and spatial memory deficits (17).”
BackgroundSelf-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“Recent therapeutic strategies have targeted both processes (6), including the inhibition of secretase enzymes to reduce Ab production, as well as active and, in particular, passive immunization approaches for boosting Ab clearance.”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · cited 1×
“Inhibition of secretases affects additional substrates with potential off-target effects (7), and passive immunization may be costly once effectiveness is demonstrated in clinical trials (8).”
Background
Cited by
Items 401–500 of 514
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease
Kofoed, R. H., Hvingelby, V. S., Pineda‐Pardo, J. A., Blesa, J., Paschen, S., Tandon, A., Joutsa, J., & Glud, A. N. (2026) · Movement Disorders · doi:10.1002/mds.70156 · Cited by 4
Wang, M., Zhang, B., Guo, R., Wang, H., Wu, D., Peng, X., Guo, H., Duan, J., Yang, W., Ren, P., et al. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108075 · Cited by 3
Simonson, W. (2015) · Geriatric Nursing · doi:10.1016/j.gerinurse.2015.08.011 · Cited by 3
Beamforming Design for High-Resolution Low-Intensity Focused Ultrasound Neuromodulation
Fan, B., Goodman, W. K., Cho, R. Y., Sheth, S. A., Bouchard, R. R., & Aazhang, B. (2020) · IEEE International Conference on Acoustics Speech and Signal Processing · doi:10.1109/icassp40776.2020.9054234 · Cited by 3
“As demonstrated by recent experiments, LIFU stimulation can even have antidepressant-like effects in rats [2] and restore the memory function in mice models of Alzheimer’s disease [3].”
BackgroundAdvances in optical imaging of drug delivery across the blood-brain barrier
Wei, W.-C., Wang, X., Li, Y., Cheng, Y., Fung, A. A., Yang, X., & Shi, L. (2021) · Progress in optics · doi:10.1016/bs.po.2021.01.002 · Cited by 3
Brain Plasticity in fMRI and DTI
Karahasanović, N., Gruber, T., Dörl, G., Radjenovic, S., Kolarova, T., Matt, E., & Beisteiner, R. (2021) · Medical radiology · doi:10.1007/978-3-030-83343-5_11 · Cited by 5
Microbubbles-based drug delivery for antiAlzheimer's drugs
Patel, M. B., Prajapati, B. G., & Yadav, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00006-6 · Cited by 3
A review on brain-targeting nano-based drug delivery
Li, P., Chen, Y., Gao, X., & Jiang, G. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1147 · Cited by 3
Recent Developments in Treating Alzheimer’s Disease
Žerovnik, E., & Kopitar‐Jerala, N. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000220 · Cited by 4
“As reported by Leinenga and Gotz, memory loss was restored in these mice [9].”
ResultRaynor, S., & Giordano, J. (2017) · Dose-Response · doi:10.1177/1559325817729247 · Cited by 3
“Clearly, a more valid, viable, and therefore valuable (n-ofone) approach would have been to (1) note that an apparent change was observed in the patient’s condition consequential to a CT scan; (2) justify the subsequent CT scans by attempting to quantify such changes—and any/all other effects— with as much methodologi…”
BackgroundBae, S., Lee, S. A., & Konofagou, E. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563176 · Cited by 3
“…focused ultrasound (Mb-FUS) is a promising non-invasive treatment for the transient and localized blood-brain barrier opening (BBBO) to enhance drug delivery (Konofagou, 2012; McMahon et al., 2021) and promote immune responses (Ji et al., 2021; Kobus et al., 2016; Leinenga & Götz, 2015).”
BackgroundLee, H., Menezes, V., Zeng, S., Kim, C., Baseman, C. M., Kim, J. H., Padmanabhan, S., Premdas, P., Djeddar, N., Bryksin, A. V., et al. (2026) · Advanced Science · doi:10.1002/advs.202517834 · Cited by 5
“In a separate cohort, we sacrificed the animals 6 h post sonication and stained the brains for astrocytosis (GFAP) and microglial activation (Iba1), which are established markers for assessing neuroinflammation [ 45, 62–64 ].”
Nanoparticles for drug delivery targeting neurodegeneration in brain and eye
Teng, F., Huang, X., Ni, R., Suen, W. L. L., & Chau, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816505-8.00006-0 · Cited by 3
Computer Simulations Aimed at Exploring Protein Aggregation and Dissociation
Nguyen, P. H., & Derreumaux, P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1546-1_9 · Cited by 2
Time-Resolved In Situ AFM Measurement of Growth Rates of Aβ40 Fibrils
Vekilov, P. G., & Wolynes, P. G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_6 · Cited by 2
Sprick, U., & Kohne, M. (2022) · International Conference on Electrical, Computer, Communications and Mechatronics Engineering (ICECCME) · doi:10.1109/iceccme55909.2022.9988704 · Cited by 3
“There is a recent report on an interesting relationship between activation of microglia by trophic factors with a subsequent reduction of plaques in a rodent model [21].”
Focused ultrasound: Innovation in use for neurologic conditions
Siyanaki, M. R. H., Pierre, K., Felisma, P., Mampre, D. M., Stein, A., Fusco, A. F., Reddy, R., Chandra, V., & Lucke-Wold, B. P. (2023) · Trauma and Emergency Medicine · doi:10.46439/trauma.1.001 · Cited by 2
“Although there is conflicting evidence regarding whether reduction of plaque size correlates with improved clinical symptoms or outcomes, studies have shown a correlation between ß-amyloid plaque reduction associated with FUS-MB and behavioral changes indicative of functional improvement in mouse models of AD [79,95].”
BackgroundExploring Acoustic Detection of α-Synuclein Fibrils
Brun-Cosme-Bruny, M., Gerfault, L., Mourier, V., Torres-Martinez, N., & Bleuet, P. (2024) · The Protein Journal · doi:10.1007/s10930-024-10241-w · Cited by 2
“While preclinical assays aim at a therapeutic objective [23–25], none has focused its research on how ultrasounds could detect and quantify fibrils.”
Scanning ultrasound elicits amyloid-β clearance in mice
Wood, H. B. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.54 · Cited by 2
Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2
Redefining Learning: A Neurocognitive Approach
Harris, P., & Walling, D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-17727-4_63-1 · Cited by 2
Man, V. H., Wang, J., Derreumaux, P., & Nguyen, P. H. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105030 · Cited by 2
Fernández-Castaño, R., Fernández‐Blázquez, M. A., Fernández, I. E., Cabrera-Freitag, M., & Freitag, K. C. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230727102025 · Cited by 3
“Preclinical studies have found that activation of microglia could lead to a more efficient brain functioning with a subsequent reduction of Aβ plaques through lysosomes [27, 28], in addition to cell proliferation [25].”
The Therapeutic Potential of Focused Ultrasound in Patients with Alzheimer’s Disease
Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., & Bogolepova, A. N. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01471-z · Cited by 3
Wang, Q., Liu, T., Chang, H., Li, Z., Chen, L., Xing, H.-Y., Wang, X., Hong, J., Liu, K., Li, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2096018/v1 · Cited by 2
Self‐Destructive Nanoscavengers Capture and Clear Neurotoxic Soluble β‐Amyloid Aggregates
Zhao, Y., Li, Q., Huang, Q., & Liu, Y. (2023) · Macromolecular Rapid Communications · doi:10.1002/marc.202300378 · Cited by 1
Safety of focused ultrasound in neuro-oncology: A summary of preclinical and clinical work
Halloran, P. J., Ray, I., Uribe-Cardenas, R., Rangaraj, R., Souweidane, M. M., & Martin, B. (2026) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdag019 · Cited by 1
Grewal, S., Iacoponi, F., Chan, L. Y. N., Dosso, V., Chang, W. L. K., Drevenakova, V., Ugwudike, A., Ricotti, L., Matthews, P. M., Cafarelli, A., et al. (2026) · npj Acoustics · doi:10.1038/s44384-026-00047-8 · Cited by 2
Wang, B., Cheng, K., Chen, Z., Chen, Y., Wang, Z., & Ni, J. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111837 · Cited by 1
Progress and challenges in drug delivery for the treatment of Alzheimer’s disease
Haghighi, F. H., Xie, J., Ebert, E., & Siahaan, T. J. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2663114 · Cited by 1
“In addition, FUS-MB alone can increase microglial activation [159,161] and neuronal plasticity in newly generated neurons [160].”
Kumar, V., Kakoty, V., & Wadhwa, P. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05901-0 · Cited by 1
Negri, S., Milan, M., Rudraboina, R., Ihuoma, J., Tavakol, S., Troyano‐Rodriguez, E., Kordestan, K. V., Csiszar, A., Yabluchanskiy, A., Youssef, I., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261447782 · Cited by 1
Current modeling approaches for drug delivery to the central nervous system
Goraya, S. A., Tzafriri, A. R., Guttmann, C. R. G., & Nezami, F. R. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2682695 · Cited by 2
Ultrasound attacks Alzheimer's disease?
Takeda, S., & Morishita, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.09.21 · Cited by 1
“reported use of ultrasound as a promising approach to clear neurotoxic amyloid plaque from the AD brain (4).”
BackgroundUltrasound as a treatment modality for neurological diseases
Leinenga, G., Nisbet, R. M., & Götz, J. (2017) · The Medical Journal of Australia · doi:10.5694/mja16.01013 · Cited by 1
Self-citationCancer Theranostics of White TiO 2Nanomaterials
Gao, Y., Sun, S., Yin, Z., Liu, Y., Wu, A., & Zeng, L. (2020) · Wiley eBooks · doi:10.1002/9783527825431.ch5 · Cited by 1
Deymier, P. A., & Runge, K. (2017) · Springer series in solid-state sciences · doi:10.1007/978-3-319-62380-1_5 · Cited by 1
Focused-ultrasound blood-brain barrier opening promotes neuroprotective microglia
Kline-Schoder, A. R., Chintamen, S., Menon, V., Kernie, S. G., & Konofagou, E. E. (2022) · IEEE International Ultrasonics Symposium · doi:10.1109/ius54386.2022.9958101 · Cited by 1
In the Slip Stream of Amyloid: The Tau and Tangle Hypothesis
Behl, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31570-1_12 · Cited by 1
Li, Y., Wu, Y., Luo, Q., Ye, X., Chen, J., Su, Y., Zhao, K., Li, X., Lin, J., Tong, Z., et al. (2024) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175231222695 · Cited by 1
“17,34,35 In the focal cerebral ischemia model mice, LIPUS at 86 mW/cm 2 , and 1.5 kHz have neuroprotective effects.”
BackgroundInfluentialJin, Z., Chen, X., Du, Z., Yuan, Y., Li, X., & Xie, P. (2024) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2024.3492158 · Cited by 1
“I N RECENT years, low-intensity transcranial ultrasound stimulation (LIPUS) has received increasing attention as an effective neuroregulatory technique [1], [2].”
Yang, W., Yu, W., & Lv, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307257 · Cited by 2
“19 In this study, we found that the expression of genes related to cellular lysosomal production in various types of AD models were enhanced to different degrees, which supports that observation.”
McMahon, D., Poon, C., Wu, S., & Hynynen, K. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_14 · Cited by 1
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Staying safe at home in winter: case studies of people with dementia
Thomas, B. (2017) · Sheffield Hallam University · doi:10.7190/shu-thesis-00078 · Cited by 1
“Therapies are being developed to reduce the causal factors related to Alzheimer's disease (Leinenga and Gotz, 2015; Sevigny et al., 2016).”
BackgroundAbjean, L., Novell, A., Larrat, B., Gueorguiev, B. R., Cailly, T., Fossey, C., Fabis, F., Salomir, R., Tsartsalis, S., Tournier, B. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614692 · Cited by 1
“In addition to inflammation modulation, different studies in mouse models of AD described a reduction of amyloid plaques after LiFUS exposure alone 17-19 , 21-23 21-23, 63-66 63-66 .”
InfluentialGerstenmayer, M. (2018) · theses.fr (ABES) · doi:10.70675/5aa7fd45z24caz43e9zaaadzeb1ca21e8661 · Cited by 5
Can Alzheimer patients receive information without using it?
Størmer, F. C. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.04.017
John, T. (2015) · Chemie in unserer Zeit · doi:10.1002/ciuz.201590051
Cheong, I. (2016) · Otago University Research Archive (University of Otago)
Traumatic Brain Injury and Neurodegenerative Disease: A Literature Review
Raiff, M. C. (2015) · Digital Commons - University of South Florida (University of South Florida)
Cellular And Molecular Mechanism Of Action Of The Amyloid-Beta Oligomer Abeta Star 56
Amar, F. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
Can Noninvasive Ultrasound Plus “Microbubbles” Clean Your Brain?
Yager, J. (2015) · Journal watch · doi:10.1056/nejm-jw.na37297
Cam, M. (2017) · theses.fr (ABES) · doi:10.70675/9cfadbadz6a4ez4260z8fe4z5caafc03a3fb
Valdez, M. A. (2017) · UA Campus Repository (The University of Arizona)
Modulation of brain activity with low intensity focused ultrasound
Constans, C. (2018) · theses.fr (ABES) · doi:10.70675/5e3876bbz0c9fz405az8d31za828c0a21055
“The main research axes are currently applications for AD [92, 115], PD [120], depression [210], OCD [94], and glioblastoma [123, 220].”
BackgroundBrain teasers: Psychiatry and allied sciences quiz
Harshe, D. G. (2018) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_51_18
“Focused skull ultrasound treatment was given to rats with Aß amyloid plaques in the brain which showed improvement.[2] An open-label trial involving five human subjects with Alzheimer’s disease showed successful opening of the blood–brain barrier after receiving focused skull ultrasound.”
BackgroundA Subject-Specific Acoustic Collimator for Multi-Index Ultrasound Neuron Modulation System
Huang, C. H., Haouari, R., Gao, H., Rochus, V., & Rottenberg, X. (2018) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2018.8580081
Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile EndotheliumPreprint
D'Arrigo, J. S. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.3041744
Karakatsani, M. E. (2020) · doi:10.7916/d8-gvqg-2009 · Cited by 1
Weber‐Adrian, D. (2017) · TSpace (University of Toronto)
Dubey, S. (2019) · TSpace (University of Toronto)
Lewis, L. A., Urban, C. M., & Hashim, S. A. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210315
Li, H., & Lewin, P. A. (2018) · iDEA - Drexel University Institutional Repository · doi:10.17918/d8p947
Meng, Y., Mithani, K., Vecchio, L. M., Aubert, I., & Lipsman, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00011-6
Ultrasound-Based Therapies for the Treatment of Cancer
Timbie, K. F. (2016) · doi:10.18130/v3wc9k
McMahon, D., & Hynynen, K. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_19 · Cited by 1
Non-pharmaceutical Treatment for Alzheimer’s Disease
Wang, X. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5795 · Cited by 1
Somatic Treatments and Neuromodulation in Psychiatry
Fitzgerald, P. B., & Arns, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_144-1
Redefining Learning: A Neurocognitive Approach
Harris, P., & Walling, D. R. (2023) · Springer eBooks · doi:10.1007/978-3-319-17461-7_63
Optical imaging technologies and applications
Wei, Z., Wang, N., Zhou, W., Chen, X., Yan, T., Zhang, J., Kang, H., Hui, H., Dong, D., & Wang, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95223-1.00030-8
Somatic Treatments and Neuromodulation in Psychiatry
Fitzgerald, P. B., & Arns, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_144 · Cited by 2
Modulating disease states of the central nervous system: Outcomes of neuromodulation on microglia
Bobotis, B. C., Dolhan, K., & Tremblay, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95730-4.00015-9
Focused ultrasound enhanced antibody delivery for the treatment of Parkinson's DiseasePreprint
Kwon, N., Batts, A. J., Zhang, H., Jackson-Lewis, V. R., Konofagou, E. E., & Przedborski, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.13.611071 · Cited by 1
“Furthermore, the effects of FUS-BBBO alone indicate a reduction of amyloid plaques and tau in animal models (17,26–28).”
BackgroundMoselmani, M., Akoum, M. A., Haddad, R., Mortada, F., Atieh, A., Malaeb, H., Jabak, Z., & Kawssan, A. (2024) · Neuroscience Updates · doi:10.47176/update.2024.53 · Cited by 1
Pople, C. B., Huang, Y., Meng, Y., & Lipsman, N. (2025) · Springer eBooks · doi:10.1007/978-3-031-80173-0_6
Intra-arterial Gene Delivery for Neurodegenerative Diseases
Fischell, J. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80173-0_14
Revolutionizing an Imaging Technology for Groundbreaking Treatment
Mertz, L. (2025) · IEEE Pulse · doi:10.1109/mpuls.2025.3554977
“These agents could then activate resident immune cells (microglia) in the brain, which are able to clear amyloid-β from the brain and restore memory [3].”
Ultrasound Enhance Drug Delivery Across Blood-Brain Barrier
Zhang, Y., Wu, X., Luo, Y., & Yan, J. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au30082
Monteiro, F., Sotiropoulos, I., Carvalho, Ó., Sousa, N., & Silva, F. S. (2021) · Figshare · doi:10.6084/m9.figshare.16680262
Mehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2024) · Figshare · doi:10.6084/m9.figshare.26597921
Leinenga, G., Koh, W. K., & Götz, J. (2021) · Figshare · doi:10.6084/m9.figshare.14396752
Self-citationMehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2024) · Figshare · doi:10.6084/m9.figshare.26597915
Mehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2024) · Figshare · doi:10.6084/m9.figshare.26597912
Leinenga, G., Koh, W. K., & Götz, J. (2021) · Figshare · doi:10.6084/m9.figshare.14396749
Self-citationChoi, H. J., Han, M., Seo, H., Park, C. Y., Lee, E.-H., & Park, J. (2024) · Figshare · doi:10.6084/m9.figshare.26557019
Kong, C., Yang, E.-J., Shin, J., Park, J., Kim, S.-H., Park, S.-W., Chang, W. S., Lee, C.-H., Kim, H., Kim, H.-S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.26557742
Mehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2024) · Figshare · doi:10.6084/m9.figshare.26597918
Lai, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1749562
Effet d'ultrasons de puissance sur les matériaux mous : vers des matériaux "acousto-rhéologiques"
Lidon, P. (2016) · theses.fr (ABES) · doi:10.70675/b2897570za9edz4ae7zb9e1z3a5ad88a0834 · Cited by 7
Magnin, R. (2016) · theses.fr (ABES) · doi:10.70675/40503805z4d35z4f50z97c9z0a86d6791c8d
ANIMAL Antidépresseurs, neuroinflammation et maladie d'alzheimer
Gosselin, T. (2016) · theses.fr (ABES) · doi:10.70675/11bcd9acz165fz4338zb013z5a469c5aed72
Signalisation IGF et maladie d'Alzheimer : mécanismes cellulaires et moléculaires
George, C. (2016) · theses.fr (ABES) · doi:10.70675/57cfde6az5061z488cz95fcz8b63f91b15e2
Maio, A. D. (2026) · TSpace (University of Toronto)
Metadata
- Authors
- Leinenga, G., & Götz, J.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Götz, Jürgen
- Venue
- Science Translational Medicine
- Published
- 2015-03-11
- Volume
- 7
- Issue
- 278
- Pages
- 278ra33-278ra33
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2169076271
- Cited by
- 498
- References
- 40
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 40 · 2023: 50 · 2022: 41 · 2021: 52 · 2020: 51 · 2019: 40 · 2018: 44 · 2017: 55 · 2016: 36 · 2015: 25
- FWCI
- 39.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council (DP130101932)
- National Health and Medical Research Council of Australia (APP1037746, APP1003150)
- ARC Linkage Infrastructure, Equipment, and Facilities (LE130100078)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, non-pharmacological treatment, amyloid plaque clearance, microglia, memory recovery, mouse model
- MeSH terms
- Albumins, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Count, Disease Models, Animal, Humans, Inflammation, Lysosomes, Memory, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Ultrasonography, Ultrasonics, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.